Mundipharma, Shionogi deal

Shionogi gained exclusive, Japanese rights to develop and commercialize Mundipharma's OxyContin Neo oxycodone and Targin oxycodone/naloxone to treat pain. Mundipharma will receive an undisclosed upf...